Literature DB >> 4032129

Defective humoral immunity in pediatric acquired immune deficiency syndrome.

L J Bernstein, H D Ochs, R J Wedgwood, A Rubinstein.   

Abstract

Specific antibody production was assessed in six young children with the acquired immune deficiency syndrome (AIDS). All patients were immunized with bacteriophage phi X 174, a T cell-dependent neoantigen. In addition, antibody responses to pneumococcal vaccine and tetanus toxoid, lymphocyte responses to mitogens, and serum immunoglobulin levels were determined. Polyclonal hypergammaglobulinemia was documented in three patients. Responses to bacteriophage phi X 174 were abnormal in all patients: primary responses were blunted, secondary responses were markedly decreased, and the class switch (IgM-IgG) was absent in five of six patients. Antibody formation to pneumococcal vaccine and tetanus toxoid was also diminished. Lymphocyte mitogenic responses to phytohemagglutinin, concanavalin A, pokeweed mitogen, and staphylococcal Cowan A were generally decreased. These findings confirm that pediatric patients with AIDS have significant abnormalities in humoral immunity. Dysfunction of both T cells and B cells plays a role in the resultant poor specific antibody production.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Antibodies; Antigen-antibody Reactions; Biology; Developed Countries; Developing Countries; Diseases; Hematological Effects; Hemic System; Hiv Infections; Immunity; Immunoglobulin Alterations; Immunologic Factors; Immunological Effects; North America; Northern America; Physiology; United States; Viral Diseases

Mesh:

Substances:

Year:  1985        PMID: 4032129     DOI: 10.1016/s0022-3476(85)80505-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  41 in total

Review 1.  Newer uses of intravenous immunoglobulins as anti-infective agents.

Authors:  J E Pennington
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

2.  Phagocytic function of monocytes in children with human immunodeficiency virus type 1 infection.

Authors:  G Tardei; D Duiculescu; C Capo; C C Diaconu; A Mutiu; J L Mege; C E Cernescu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

3.  Immunotherapy for infectious diseases.

Authors:  J E Pennington
Journal:  West J Med       Date:  1990-04

Review 4.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

5.  Antibody response to inactivated polio vaccine (E-IPV) in children born to HIV positive mothers.

Authors:  M Barbi; M Bardare; C Luraschi; G Zehender; M Clerici Schoeller; G Ferraris
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

6.  Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.

Authors:  Stephanie A Planque; Yukie Mitsuda; Vida Chitsazzadeh; Santhi Gorantla; Larisa Poluektova; Yasuhiro Nishiyama; Christina Ochsenbauer; Mary-Kate Morris; Gopal Sapparapu; Carl V Hanson; Richard J Massey; Sudhir Paul
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

Review 7.  Does intravenous immune globulin have a role in HIV-infected patients?

Authors:  P L Yap
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  High-dose intravenous immunoglobulins in the treatment of adolescent and adult HIV-infected hemophiliacs.

Authors:  U Wintergerst; K Niinivaara-Kreuzer; G Notheis; K Auberger; C Brückmann; S Gandenberger; B H Belohradsky
Journal:  Clin Investig       Date:  1994-01

9.  Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.

Authors:  M R Dawood; B Conway; P Patenaude; F Janmohamed; J S Montaner; M V O'Shaughnessy; G W Hammond
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

10.  C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection.

Authors:  Catherine Hyams; Jerry C H Tam; Jeremy S Brown; Stephen B Gordon
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.